In OS, as well as in other cancers, EPCs respond to a gradient of angiogenic cytokines, including VEGF, FGF, and SDF-A, which are released from ischemic zones, including the hypoxic tumor microenvironment (TME) [19]. The gene discussed is VEGFA; the disease is neoplasm.